← Back to headlines
VERAXA Biotech Secures $27.5M Financing and Plans SPAC Merger
VERAXA Biotech has announced it secured $27.5 million in financing and intends to go public through a SPAC merger.
28 May, 16:53 — 28 May, 16:53
Sources
Showing 1 of 1 sources
Related Stories
Hedge Fund Agrees to £1 Billion Takeover of UK’s Spire Healthcare
28m ago
OPEC+ Maintains October Oil Output Quotas Amid Shifting Global Focus
31m ago
WEPSEA 2026 Concludes With Focus on Sustainable Packaging in Southeast Asia
54m ago
South Korea and US Agree on $20 Billion Texas Gas Plant Investment
1h ago